Ducommun DCO Military and space — Net Revenues

Other product segments

Similar metrics at other companies

ANIPGenerics and Other total net revenues — Net Revenues

$100.66M+6.8%

ANIPRare Disease and Brands total net revenues — Net Revenues

$165.39M+41.2%

ANIPBrand royalties and other revenues — Net Revenues

$17.73M—

ANIPILUVIEN and YUTIQ — Net Revenues

$18.72M-16.1%

ANIPRare Disease total net revenues — Net Revenues

$135.84M+30.7%

ANIPOther generic revenues — Net Revenues

$1.61M-59.0%

FAQ

What is Ducommun's military and space — net revenues?

Ducommun (DCO) reported military and space — net revenues of $123.75M in Q2 2026.

How has Ducommun's military and space — net revenues changed year-over-year?

Ducommun's military and space — net revenues increased by 6.8% year-over-year, from $115.88M to $123.75M.

What is the long-term trend for Ducommun's military and space — net revenues?

Over 4 years (2021 to 2025), Ducommun's military and space — net revenues has grown at a 1.3% compound annual growth rate (CAGR), from $453.85M to $477.4M.

What does military and space — net revenues mean?

Represents the total gross sales generated from products and services specifically tailored for military, defense, and aerospace applications. This metric reflects the company's market penetration and demand within high-reliability sectors that require specialized engineering and manufacturing capabilities. It serves as a primary indicator of the segment's scale and its contribution to the overall corporate top-line performance.